China SXT Pharmaceuticals, Inc. (SXTC) reporting calendar
China SXT Pharmaceuticals, Inc. files periodic reports with the SEC as SXTC on Nasdaq. Atlas tracks 8 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Mar 2026
- Filed
- 1 Jul 2026
- Reports on record
- 8
Open SXTC market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Mar 2026 | 1 Jul 2026 | 92 days | 0001213900-26-074310 |
| 20-F | 31 Mar 2025 | 31 Jul 2025 | 122 days | 0001213900-25-069688 |
| 20-F | 31 Mar 2024 | 13 Aug 2024 | 135 days | 0001213900-24-068266 |
| 20-F | 31 Mar 2023 | 31 Jul 2023 | 122 days | 0001213900-23-061294 |
| 20-F | 31 Mar 2022 | 18 Jul 2022 | 109 days | 0001213900-22-039838 |
| 20-F | 31 Mar 2021 | 13 Aug 2021 | 135 days | 0001213900-21-042555 |
| 20-F | 31 Mar 2020 | 31 Jul 2020 | 122 days | 0001213900-20-019503 |
| 20-F | 31 Mar 2019 | 15 Aug 2019 | 137 days | 0001213900-19-016026 |
Source: SEC EDGAR company submissions for CIK 0001723980. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.